The future of inhalers: how can we improve drug delivery in asthma and COPD?

References

• Virchow JC. What plays a role in the choice of inhaler device for asthma therapy? Curr Med Res Opin. 2005;21(Suppl 4):S19–S25.
   PubMed Web of Science ®Google Scholar
• Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy. 2013;2013:102418.
   PubMedGoogle Scholar
• WHO. Chronic obstructive pulmonary disease (COPD). Geneva: WHO; 2015.
   Google Scholar
• Chan JG, Wong J, Zhou QT, et al. Advances in device and formulation technologies for pulmonary drug delivery. AAPS PharmSciTech. 2014;15(4):882–897.
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices. 2015;8:131–139.
   Google Scholar
• Vanderman AJ, Moss JM, Bailey JC, et al. Inhaler misuse in an older adult population. Consult Pharm. 2015;30(2):92–100.
   PubMedGoogle Scholar
• Bateman ED. Treatment adherence in asthmatic patients: the last frontier? J Allergy Clin Immunol. 2014;134(6):1269–1270.
   PubMed Web of Science ®Google Scholar
• Roy A, Battle K, Lurslurchachai L, et al. Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma. Prim Care Respir J. 2011;20(2):148–154.
   PubMedGoogle Scholar
• Barnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–468.
   PubMed Web of Science ®Google Scholar
• Fink JB. Inhalers in asthma management: is demonstration the key to compliance? Respir Care. 2005;50(5):598–600.
   PubMedGoogle Scholar
• Hoppentocht M, Hagedoorn P, Frijlink HW, et al. Technological and practical challenges of dry powder inhalers and formulations. Adv Drug Deliv Rev. 2014;75:18–31.
   PubMed Web of Science ®Google Scholar
• Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc. 2004;1(4):315–320.
   PubMedGoogle Scholar
• Chrystyn H, Price DB, Molimard M, et al. Comparison of serious inhaler technique errors made by device-naive patients using three different dry powder inhalers: a randomised, crossover, open-label study. BMC Pulm Med. 2016;16:12.
   PubMed Web of Science ®Google Scholar
• Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335–371.
   PubMed Web of Science ®Google Scholar
• Williams MV, Baker DW, Honig EG, et al. Inadequate literacy is a barrier to asthma knowledge and self-care. Chest. 1998;114(4):1008–1015.
   PubMed Web of Science ®Google Scholar
• van Aalderen WM, Garcia-Marcos L, Gappa M, et al. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. Npj Prim Care Resp M. 2015;25. doi:10.1038/npjpcrm.2014.88
   PubMed Web of Science ®Google Scholar
• Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384.
   PubMedGoogle Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Bonini M, Usmani O. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1(9). doi:10.1186/s40749-015-0011-0
   Google Scholar
• Inhaler Error Steering C, Price D, Bosnic-Anticevich S, Briggs A, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013;107(1):37–46.
   PubMed Web of Science ®Google Scholar
• Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care. 2005;50(10):1346–1356; discussion 57–9.
   Google Scholar
• Price D, Chrystyn H, Kaplan A, et al. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res. 2012;4(4):184–191.
   PubMed Web of Science ®Google Scholar
• Rootmensen GN, van Keimpema AR, Jansen HM, et al. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. J Aerosol Med Pulm Drug Deliv. 2010;23(5):323–328.
   PubMed Web of Science ®Google Scholar
• Lavorini F, Braido F, Baiardini I, et al. Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR). Pulm Pharmacol Ther. 2015;34:25–30.
   PubMed Web of Science ®Google Scholar
• Scichilone N, Benfante A, Bocchino M, et al. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? Pulm Pharmacol Ther. 2015;31:63–67.
   PubMed Web of Science ®Google Scholar
• Kim M, Henderson K, Van Sickle D, editors. Using connected devices to monitor inhaler use in the real world. Respiratory drug delivery 2016. Pheonix, AZ, USA: Davis Helthcare International Publishing, LLC; 2016.
   Google Scholar
• Virchow JC, Akdis CA, Darba J, et al. A review of the value of innovation in inhalers for COPD and asthma. J Mark Access Health Policy. 2015;3:1–8.
   PubMedGoogle Scholar
• van der Palen J, Klein J, Kerkhoff A, et al. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. Patient Educ Couns. 1997;32(1 Suppl):S87–S95.
   Google Scholar
• Price D, Roche N, Christian Virchow J, et al. Device type and real-world effectiveness of asthma combination therapy: an observational study. Respir Med. 2011;105(10):1457–1466.
   PubMed Web of Science ®Google Scholar
• Van Arnum P. Tracking Pharmaceutical and API Growth in China; 2011. [cited 2016 May 18]. Available from: http://www.pharmtech.com/tracking-pharmaceutical-and-api-growth-china
   Google Scholar